| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.32M | - | |
| Other | 67.7K | $2.42M | - | |
| CFO | 40.3K | $1.44M | - | |
| Other | 34.6K | $1.24M | - | |
| Dir | 17.8K | $634.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2017 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 6,000 | $66.76 | $400,560.00 | -100% | |
| Sep 18, 2017 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 35,000 | $67.12 | $2,349,200.00 | -100% | |
| Sep 14, 2017 | Cantley Lewis Clayton Jr. | Director | Sell | 4,000 | $65.59 | $262,360.00 | -1.2% | |
| Sep 11, 2017 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 6,000 | $65.00 | $390,000.00 | -87.2% | |
| Sep 11, 2017 | Biller Scott | Chief Scientific Officer | Sell | 15,000 | $65.00 | $975,000.00 | -58.9% | |
| Sep 1, 2017 | Biller Scott | Chief Scientific Officer | Sale+OE | 2,146 | $61.99 | $133,030.54 | -25.5% | |
| Sep 1, 2017 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 6,000 | $62.20 | $373,200.00 | -100% | |
| Aug 23, 2017 | Cantley Lewis Clayton Jr. | Director | Sell | 4,000 | $56.85 | $227,400.00 | -0.6% | |
| Aug 2, 2017 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 27,000 | $59.95 | $1,618,560.00 | -100% | |
| Aug 2, 2017 | Biller Scott | Chief Scientific Officer | Sale+OE | 23,146 | $59.60 | $1,379,397.30 | -42.2% |